Pain News and Research

Latest Pain News and Research

Ultrasound may help predict future tendon injuries in dancers

Asymptomatic focal hypoechoic changes in the patellar and achilles tendons moderately increase the risk for future injury in professional dancers, show study findings.

15 Oct 2012

Therapeutic HPV16 and HPV18 vaccine ‘may eliminate infection’

A candidate vaccine against human papillomavirus serotypes 16 and 18 appears to induce robust immune responses to antigens, potentially leading to the elimination of virus-infected cells and regression of dysplasia, say US investigators.

15 Oct 2012

Embryonic neuron transplants could effectively treat brain diseases

The unexpected survival of embryonic neurons transplanted into the brains of newborn mice in a series of experiments at the University of California, San Francisco (UCSF) raises hope for the possibility of using neuronal transplantation to treat diseases like Alzheimer's, epilepsy, Huntington's, Parkinson's and schizophrenia.

15 Oct 2012

Language disparities impact Hispanic women during labor

A study presented at the ANESTHESIOLOGY 2012 annual meeting found the role of women's primary language impacts whether or not they receive an epidural for pain relief during labor.

15 Oct 2012

Gardasil does not increase sexual activity in girls

The human papillomavirus (HPV) vaccine known as Gardasil is not associated with an increase in pregnancy, sexually transmitted infections, or contraceptive counseling, according to a Kaiser Permanente study published online today in the journal Pediatrics.

15 Oct 2012

Merck announces results from odanacatib Phase II trial on post-menopausal osteoporosis

Merck, known as MSD outside the United States and Canada, today announced results from a Phase II trial for odanacatib, an investigational cathepsin K (cat-K) inhibitor in development for the treatment of osteoporosis in post-menopausal women.

15 Oct 2012

Celgene receives FDA approval for ABRAXANE to treat non-small cell lung cancer

Celgene Corporation today announced the U.S. Food and Drug Administration (FDA) has approved ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for the first-line treatment of locally advanced or metastatic non-small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy.

15 Oct 2012

FDA expands approved indication for Genentech’s ACTEMRA to treat active rheumatoid arthritis

Genentech, Inc., a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved indication for ACTEMRA (tocilizumab) for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more disease-modifying antirheumatic drugs (DMARDs).

13 Oct 2012

National Rheumatoid Arthritis Society to publish new Responsibility Deal

No one can have failed to notice the austerity measures being put in place across all government departments with "we're in this together" becoming the rallying cry of the coalition government. In the spirit of this, the National Rheumatoid Arthritis Society are using the occasion of World Arthritis Day on the 12th October to publish their new Responsibility Deal, demonstrating that as well as rights, patients also have responsibilities, as do all those involved in the health, social care and policy making process.

12 Oct 2012

$IOF report: 80% of patients with fracture are not screened for osteoporosis or risk of future falls$

IOF report: 80% of patients with fracture are not screened for osteoporosis or risk of future falls

Today, the International Osteoporosis Foundation (IOF) released a new report, revealing approximately 80 percent of patients treated in clinics or hospitals following a fracture are not screened for osteoporosis or risk of future falls. Left untreated, these patients are at high risk of suffering secondary fractures and facing a future of pain, disfigurement, long-term disability and even early death.

12 Oct 2012

AIUM to host Ultrasound First Forum on Nov. 12

The American Institute of Ultrasound in Medicine (AIUM) will host an Ultrasound First Forum on November 12, 2012, in New York, New York. The forum will address the expanding role of ultrasound imaging as a "first" imaging examination and will be devoted to encouraging the use of ultrasound as a safe, effective, and affordable alternative to other diagnostic imaging modalities where scientific evidence supports its appropriateness.

12 Oct 2012

Study compares two drug combinations for use as deep sedation during oral surgery

The ideal sedative for oral surgery should make the patient comfortable during the surgery and should wear off quickly enough that the patient can leave the dental chair soon after the procedure. Finding the best plan of anesthetic treatment is essential to the success of dental procedures such as the extraction of wisdom teeth.

12 Oct 2012

Bidirectional communication between breast cancer cells and nearby MSCs cause metastasis

In recent years investigators have discovered that breast tumors are influenced by more than just the cancer cells within them. A variety of noncancerous cells, which in many cases constitute the majority of the tumor mass, form what is known as the "tumor microenvironment."

12 Oct 2012

Menstrual cycle alters muscle activation patterns in female athletes

Numerous studies have shown that female athletes are more likely to get knee injuries, especially anterior cruciate ligament (ACL) tears and chronic pain, than their male counterparts.

12 Oct 2012

Regenstrief, IU to work with 19 Indiana nursing facilities to improve quality of care

A multi-million-dollar award from the Centers for Medicare & Medicaid Services, or CMS, will enable Indiana University and Regenstrief Institute clinician-researchers to work with 19 central Indiana nursing facilities to improve the quality of care, reduce hospitalizations and increase access to palliative care for long-stay nursing facility residents.

12 Oct 2012

Top-line results from Pfizer’s ALO-02 Phase 3 study on chronic non-cancer pain

Pfizer Inc. announced top-line results today from a Phase 3 open-label long-term safety study of investigational agent ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride extended-release capsules) in patients with moderate-to-severe chronic, non-cancer pain.

12 Oct 2012

Tourniquet timing alters foot surgery pain outcomes

The timing of thigh tourniquet application may affect pain control in patients undergoing forefoot surgery, research published in Foot and Ankle Surgery suggests.

11 Oct 2012

Theragenics enters second amended and restated credit agreement with Wells Fargo

Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has entered into a Second Amended and Restated Credit Agreement with Wells Fargo Bank, National Association.

11 Oct 2012

Grand Challenges Canada funds 15 new projects to improve mental health diagnosis and care

Grand Challenges Canada, which is funded by the Government of Canada, today announced a landmark $19.4 million in support of 15 innovative, pioneering projects designed to improve mental health diagnosis and care in developing countries, many of them nations ravaged by conflict and disaster as well as poverty.

11 Oct 2012

USC project seeks to answer important questions about cancer

Three groups of University of Southern California (USC) researchers-representing medicine, chemistry and chemical engineering-are recipients of highly competitive grants from the National Institutes of Health's National Cancer Institute (NCI).

11 Oct 2012

Pain News and Research

Latest Pain News and Research

Ultrasound may help predict future tendon injuries in dancers

Therapeutic HPV16 and HPV18 vaccine ‘may eliminate infection’

Embryonic neuron transplants could effectively treat brain diseases

Language disparities impact Hispanic women during labor

Gardasil does not increase sexual activity in girls

Merck announces results from odanacatib Phase II trial on post-menopausal osteoporosis

Celgene receives FDA approval for ABRAXANE to treat non-small cell lung cancer

FDA expands approved indication for Genentech’s ACTEMRA to treat active rheumatoid arthritis

National Rheumatoid Arthritis Society to publish new Responsibility Deal

IOF report: 80% of patients with fracture are not screened for osteoporosis or risk of future falls

AIUM to host Ultrasound First Forum on Nov. 12

Study compares two drug combinations for use as deep sedation during oral surgery

Bidirectional communication between breast cancer cells and nearby MSCs cause metastasis

Menstrual cycle alters muscle activation patterns in female athletes

Regenstrief, IU to work with 19 Indiana nursing facilities to improve quality of care

Top-line results from Pfizer’s ALO-02 Phase 3 study on chronic non-cancer pain

Tourniquet timing alters foot surgery pain outcomes

Theragenics enters second amended and restated credit agreement with Wells Fargo

Grand Challenges Canada funds 15 new projects to improve mental health diagnosis and care

USC project seeks to answer important questions about cancer

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Pain News and Research

Latest Pain News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in